For Global Healthcare Startups
Your Roadmap to Global MNC Partnership
You've built something world-class in biotech, MedTech, diagnostics or digital health. The world's largest healthcare companies are hunting for it — we make sure they find you.
We know where you're standing
The Distance Between a Breakthrough and a Term Sheet
50% of big pharma and MedTech pipelines now come from startups. $197B in cross-border out-licensing deals in 2025. The demand is real. What's missing is the road.
Your challenge
- No structured pathway to MNC partners — just cold emails and conference badge scans
- Traditional BD takes 2–4 years while your runway burns
- Compliance surprises — CFIUS, export controls — that surface late in diligence
- No pre-valuation, so every negotiation starts from zero
Your opportunity
- 50% of big pharma & MedTech pipelines now sourced from startups
- A $197B cross-border out-licensing wave in 2025
- AI pre-match surfaces your 3–5 ideal MNC partners
- 8–12x faster time-to-deal with AI pre-match
Our promise
- IAD listing with AI scoring and a pre-valuation report
- Full advisory stack: FDA/IND, IP, CFIUS/BIS/NMPA, NewCo
- Site immersion into US innovation hubs plus matched 1:1 MNC meetings
- Deal facilitation through term sheet, NewCo formation and co-investment
The road, chapter by chapter
From Lab Bench to Global Term Sheet
The groundwork
We validate the science and lay the advisory groundwork — regulatory pathway (FDA/IND), IP strategy, and compliance pre-clearance — so nothing surfaces late in diligence.
The spotlight
Your asset joins the Innovation Assets Database (IAD): AI-scored, pre-valued, and previewed by matched MNC BD teams and investors 30 days before the open market sees it.
The crossing
Site immersion into US innovation hubs — with 1:1 meetings booked with your 3–5 matched MNC partners before you board the flight.
The signature
Term-sheet negotiation, compliant deal structure, NewCo formation and co-investment — the paperwork of the deal, handled by people who've closed before.
The breakthrough is yours. The bridge is ours.
The global stage is calling. Your breakthrough deserves a global deal.
Start with one conversation — confidential, and built around your asset.